Literature DB >> 20353274

Increased 18F-FDG uptake and expression of Glut1 in the EMT transformed breast cancer cells induced by TGF-beta.

W Li1, Z Wei, Y Liu, H Li, R Ren, Y Tang.   

Abstract

As carcinomas progress, the tumors may lose epithelial morphology and acquire mesenchymal characteristics typically called epithelial-mesenchymal transition (EMT), which is commonly associated with increased cell migration, enables cells to dissociate from their original tissue and form metastasis in distant organs. In addition to molecular and morphologic changes, the EMT transformed cells also showed the change of sensitivity to chemotherapeutics. In order to detect the EMT transition in vivo clinically, we detected the change of metabolism of MCF-7 cells after being induced by TGF-beta to form EMT condition by MTT and 18F-FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353274     DOI: 10.4149/neo_2010_03_234

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  20 in total

1.  18F-FDG-PET/CT predicts the distribution of microsatellite lesions in hepatocellular carcinoma.

Authors:  Hironori Ochi; Masashi Hirooka; Atsushi Hiraoka; Yohei Koizumi; Masanori Abe; Ichiro Sogabe; Yoshihiro Ishimaru; Keizou Furuya; Masao Miyagawa; Hideki Kawasaki; Kojiro Michitaka; Yasutsugu Takada; Teruhito Mochizuki; Yoichi Hiasa
Journal:  Mol Clin Oncol       Date:  2014-06-25

2.  Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma.

Authors:  Menghan Liu; Lake-Ee Quek; Ghazal Sultani; Nigel Turner
Journal:  Cancer Metab       Date:  2016-10-17

3.  Secreted frizzled-related protein 1 overexpression in gastric cancer: Relationship with radiological findings of dual-energy spectral CT and PET-CT.

Authors:  Huimin Lin; Guoyuan Yang; Bei Ding; Miao Zhang; Mingjun Zhang; Fuhua Yan; Ying Qu; Huan Zhang
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

4.  TGFBR-IDH1-Cav1 axis promotes TGF-β signalling in cancer-associated fibroblast.

Authors:  Xiaodan Hou; Jieying Zhang; Yongbin Wang; Wujun Xiong; Jun Mi
Journal:  Oncotarget       Date:  2017-09-13

5.  LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism.

Authors:  Jinxue Zhang; Yuan Zhang; Shiyang Cheng; Yang Mu; Yongming Liu; Xin Yi; Dongxu Jiang; Yong Ding; Ran Zhuang
Journal:  World J Surg Oncol       Date:  2020-06-20       Impact factor: 2.754

6.  Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.

Authors:  Satoru Komaki; Yasuo Sugita; Takuya Furuta; Kyohei Yamada; Mayuko Moritsubo; Hideyuki Abe; Jun Akiba; Naohisa Miyagi; Hideo Nakamura; Hiroaki Miyoshi; Koichi Ohshima; Motohiro Morioka
Journal:  J Neuropathol Exp Neurol       Date:  2019-05-01       Impact factor: 3.685

7.  Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells.

Authors:  Menghan Liu; Sarah E Hancock; Ghazal Sultani; Brendan P Wilkins; Eileen Ding; Brenna Osborne; Lake-Ee Quek; Nigel Turner
Journal:  J Clin Med       Date:  2019-06-08       Impact factor: 4.241

Review 8.  TGF-β links glycolysis and immunosuppression in glioblastoma.

Authors:  Lingli Gong; Li Ji; Daxing Xu; Jingjing Wang; Jian Zou
Journal:  Histol Histopathol       Date:  2021-07-29       Impact factor: 2.303

9.  LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer.

Authors:  Yongjie Zhang; Sen Lin; Yan Chen; Fei Yang; Shenlin Liu
Journal:  Onco Targets Ther       Date:  2018-04-27       Impact factor: 4.147

10.  Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation.

Authors:  Katharina Kinslechner; David Schörghofer; Birgit Schütz; Maria Vallianou; Bettina Wingelhofer; Wolfgang Mikulits; Clemens Röhrl; Markus Hengstschläger; Richard Moriggl; Herbert Stangl; Mario Mikula
Journal:  Mol Cancer Res       Date:  2017-10-03       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.